Irinotecan liposome Intravenous and Lenvatinib Mesylate
Determining the interaction of Irinotecan liposome Intravenous and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: irinotecan liposomal
Brand name: Onivyde
Synonyms: Irinotecan liposomal, Irinotecan (Liposomal)
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Irinotecan liposome Intravenous-Lenvima
- Irinotecan liposome Intravenous-Lenvima (14 MG Daily Dose)
- Irinotecan liposome Intravenous-Lenvima (18 MG Daily Dose)
- Irinotecan liposome Intravenous-Lenvima (20 MG Daily Dose)
- Irinotecan liposome Intravenous-Lenvima (24 MG Daily Dose)
- Irinotecan liposome Intravenous-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Iron 100/C
- Lenvatinib Mesylate-Iron 21/7
- Lenvatinib Mesylate-Iron and Docusate
- Lenvatinib Mesylate-Iron and Folic Acid
- Lenvatinib Mesylate-Iron and Vitamin C
- Lenvatinib Mesylate-Iron Chewable Tablets